Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fumi Minoshima"'
Publikováno v:
iScience, Vol 24, Iss 8, Pp 102882- (2021)
Summary: Single-cell sequencing has emerged as an indispensable technology to dissect cellular heterogeneity but never been applied to the simultaneous analysis of glycan and RNA. Using oligonucleotide-labeled lectins, we first established lectin-bas
Externí odkaz:
https://doaj.org/article/139f4a28d07340809cb02b9043c58c62
Elimination of Tumorigenic Human Pluripotent Stem Cells by a Recombinant Lectin-Toxin Fusion Protein
Autor:
Hiroaki Tateno, Yasuko Onuma, Yuzuru Ito, Fumi Minoshima, Sayoko Saito, Madoka Shimizu, Yasuhiko Aiki, Makoto Asashima, Jun Hirabayashi
Publikováno v:
Stem Cell Reports, Vol 4, Iss 5, Pp 811-820 (2015)
The application of stem-cell-based therapies in regenerative medicine is hindered by the tumorigenic potential of residual human pluripotent stem cells. Previously, we identified a human pluripotent stem-cell-specific lectin probe, called rBC2LCN, by
Externí odkaz:
https://doaj.org/article/6743cf5c3e68469e83275a88df19bca8
Publikováno v:
Molecules, Vol 22, Iss 7, p 1151 (2017)
The use of human pluripotent stem cells (hPSCs) such as human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) in regenerative medicine is hindered by their tumorigenic potential. Previously, we developed a recombinant l
Externí odkaz:
https://doaj.org/article/aa7986f66f8141b4ab6818d6f8d7cb4f
Publikováno v:
ISME Communications. 2
Bacterial glycans modulate the cross talk between the gut microbiota and its host. However, little is known about these glycans because of the lack of appropriate technology to study them. In this study, we applied Glycan-seq technology for glycan pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35ff417a484f9c3600bd3f17b7d4def6
https://doi.org/10.1038/s43705-021-00084-2
https://doi.org/10.1038/s43705-021-00084-2
Publikováno v:
iScience, Vol 24, Iss 8, Pp 102882-(2021)
iScience
iScience
Summary Single-cell sequencing has emerged as an indispensable technology to dissect cellular heterogeneity but never been applied to the simultaneous analysis of glycan and RNA. Using oligonucleotide-labeled lectins, we first established lectin-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c340fb4c5b05827e8cbccbb72025e21
http://www.sciencedirect.com/science/article/pii/S2589004221008506
http://www.sciencedirect.com/science/article/pii/S2589004221008506
BackgroundThere has been immense interest in studying the relationship between the gut microbiota and human health. Bacterial glycans modulate the cross talk between the gut microbiota and its host. However, little is known about these glycans becaus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70f2b1d6195a6eeb7078764027eb8a10
https://doi.org/10.1101/2021.06.30.450488
https://doi.org/10.1101/2021.06.30.450488
Autor:
Junko Katayama, Kayo Kiyoi, Kazutaka Matoba, Yoichi Kumada, Fumi Minoshima, Hiroaki Tateno, Keiko Hiemori
Publikováno v:
Journal of bioscience and bioengineering. 129(2)
Human pluripotent stem cells (hPSCs) are considered ideal cell sources for regenerative medicine, but their clinical and industrial applications are hindered by their tumorigenic potential. We previously identified an hPSC-specific lectin, rBC2LCN, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c732fa1f5611e7b9e7971aef3e132a91
https://pubmed.ncbi.nlm.nih.gov/31473147
https://pubmed.ncbi.nlm.nih.gov/31473147
Publikováno v:
Chembiochem : a European journal of chemical biology. 20(12)
Human pluripotent stem cells (hPSCs) are attractive resources for regenerative medicine, but medical applications are hindered by their tumorigenic potential. Previously, a hPSC-specific lectin probe, rBC2LCN, was identified through comprehensive gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9164064674728e635b80ddbf4e1ce3
https://pubmed.ncbi.nlm.nih.gov/30737871
https://pubmed.ncbi.nlm.nih.gov/30737871
Elimination of Tumorigenic Human Pluripotent Stem Cells by a Recombinant Lectin-Toxin Fusion Protein
Autor:
Yasuhiko Aiki, Hiroaki Tateno, Makoto Asashima, Yasuko Onuma, Yuzuru Ito, Jun Hirabayashi, Fumi Minoshima, Sayoko Saito, Madoka Shimizu
Publikováno v:
Stem Cell Reports, Vol 4, Iss 5, Pp 811-820 (2015)
Stem Cell Reports
Stem Cell Reports
Summary The application of stem-cell-based therapies in regenerative medicine is hindered by the tumorigenic potential of residual human pluripotent stem cells. Previously, we identified a human pluripotent stem-cell-specific lectin probe, called rBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a685fb5788446d5ef2fe46d1d1c9eb89
http://www.sciencedirect.com/science/article/pii/S2213671115000727
http://www.sciencedirect.com/science/article/pii/S2213671115000727